Mergers and Acquisitions - Harbin Pharmaceutical Group plans to acquire 42.82% equity of Sanjing Qianhe Pharmaceutical for 23.446 million yuan [1] - Xinjiang Torch intends to purchase 100% equity of Yushan Litai for 125 million yuan, which is classified as a related party transaction but not a major asset restructuring [2] Share Buybacks - Rongxin Culture announces a share buyback plan with a budget between 20 million and 22 million yuan, with a maximum buyback price of 37 yuan per share [3] - Weifu High Science plans to repurchase shares with a budget of 100 million to 150 million yuan, with a maximum buyback price of 35 yuan per share [4] Shareholding Changes - Hubei Yihua's controlling shareholder plans to increase its stake in the company by investing between 200 million and 400 million yuan within six months starting from May 19, 2025, without a price range [5] - Fuchuang Precision announces that two shareholders plan to collectively reduce their holdings by up to 4% of the total shares [6] - Hanchuan Intelligent's controlling shareholder received a warning from Jiangsu Securities Regulatory Commission for failing to disclose significant risks related to pledge contracts [7] - Delin Hai's shareholder plans to reduce holdings by up to 3% of the total shares due to personal financial needs [8]
新疆火炬拟1.25亿元收购玉山利泰100%股权;富创精密两股东拟合计减持不超过4%股份丨公告精选